Literature DB >> 25527569

Identification of IG-clonality status as a pre-treatment predictor for mortality in patients with immunodeficiency-associated Epstein-Barr virus-related lymphoproliferative disorders.

Walter J F M van der Velden1, Loes Nissen2, Marieke van Rijn2, Jos Rijntjes3, Anton de Haan4, Lakshmi Venkatraman5, Mark Catherwood5, Hongxiang Liu6, Hesham El-Daly7, Lisette van de Laar3, Moniek H C Craenmehr3, J Han J M van Krieken3, Wendy B C Stevens1, Patricia J T A Groenen8.   

Abstract

Entities:  

Keywords:  Epstein-Barr virus; IG-clonality; immunodeficiency; lymphoproliferative disorders; mortality; predictor

Mesh：

Substances：

Year:  2014        PMID： 25527569      PMCID： PMC4380739          DOI： 10.3324/haematol.2014.116780

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin's lymphomas with high rates of somatic hypermutation.

Authors:  Mark A Catherwood; David Gonzalez; Caroline Patton; Edwina Dobbin; Lakshmi Venkatraman; H Denis Alexander
Journal:  J Clin Pathol       Date:  2006-06-30       Impact factor: 3.411

2.  Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.

Authors:  P A S Evans; Ch Pott; P J T A Groenen; G Salles; F Davi; F Berger; J F Garcia; J H J M van Krieken; S Pals; Ph Kluin; E Schuuring; M Spaargaren; E Boone; D González; B Martinez; R Villuendas; P Gameiro; T C Diss; K Mills; G J Morgan; G I Carter; B J Milner; D Pearson; M Hummel; W Jung; M Ott; D Canioni; K Beldjord; C Bastard; M H Delfau-Larue; J J M van Dongen; T J Molina; J Cabeçadas
Journal:  Leukemia       Date:  2006-12-14       Impact factor: 11.528

3.  Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  A W Langerak; T J Molina; F L Lavender; D Pearson; T Flohr; C Sambade; E Schuuring; T Al Saati; J J M van Dongen; J H J M van Krieken
Journal:  Leukemia       Date:  2006-12-14       Impact factor: 11.528

4.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

5.  Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients.

Authors:  D E Tsai; C L Hardy; J E Tomaszewski; R M Kotloff; K M Oltoff; B G Somer; S J Schuster; D L Porter; K T Montone; E A Stadtmauer
Journal:  Transplantation       Date:  2001-04-27       Impact factor: 4.939

6.  Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab.

Authors:  W J F M van der Velden; T Mori; W B C Stevens; A F J de Haan; F F Stelma; N M A Blijlevens; J P Donnelly
Journal:  Bone Marrow Transplant       Date:  2013-06-10       Impact factor: 5.483

Review 7.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

8.  Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Authors:  Ralf Trappe; Stephan Oertel; Veronique Leblond; Peter Mollee; Monica Sender; Petra Reinke; Ruth Neuhaus; Hans Lehmkuhl; Heinz August Horst; Gilles Salles; Franck Morschhauser; Arnaud Jaccard; Thierry Lamy; Malte Leithäuser; Heiner Zimmermann; Ioannis Anagnostopoulos; Martine Raphael; Hanno Riess; Sylvain Choquet
Journal:  Lancet Oncol       Date:  2011-12-13       Impact factor: 41.316

Review 9.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

Review 10.  EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.

Authors:  A W Langerak; P J T A Groenen; M Brüggemann; K Beldjord; C Bellan; L Bonello; E Boone; G I Carter; M Catherwood; F Davi; M-H Delfau-Larue; T Diss; P A S Evans; P Gameiro; R Garcia Sanz; D Gonzalez; D Grand; A Håkansson; M Hummel; H Liu; L Lombardia; E A Macintyre; B J Milner; S Montes-Moreno; E Schuuring; M Spaargaren; E Hodges; J J M van Dongen
Journal:  Leukemia       Date:  2012-08-24       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.